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In 1965, an adult-onset, autosomal dominant disorder with a peculiar scapuloperoneal distribution of weakness
and atrophy was described in a large, multi-generation kindred and named ‘scapuloperoneal syndrome type
Kaeser’ (OMIM #181400). By genetic analysis of the original kindred, we discovered a heterozygous missense
mutation of the desmin gene (R350P) cosegregating with the disorder. Moreover, we detected DES R350P in
four unrelated German families allowing for genotype^phenotype correlations in a total of 15 patients carrying
the same mutation. Large clinical variability was recognized, even within the same family, ranging from scapu-
loperoneal (n¼ 2, 12%), limb girdle (n¼10, 60%) and distal phenotypes (n¼ 3, 18%) with variable cardiac (n¼ 7,
41%) or respiratory involvement (n¼ 7, 41%). Facial weakness, dysphagia and gynaecomastia were frequent addi-
tional symptoms.Overall and within each family, affected men seemingly bear a higher risk of sudden, cardiac
death as compared to affected women.Moreover, histological and immunohistochemical examination of muscle
biopsy specimens revealed a wide spectrum of findings ranging from near normal or unspecific pathology to
typical, myofibrillar changes with accumulation of desmin.This study reveals that the clinical and pathological
variability generally observed in desminopathiesmay not be attributed to the nature of the DESmutation alone,
but may be influenced by additional genetic and epigenetic factors such as gender. In addition, mutations of the
desmin gene should be considered early in the diagnostic work-up of any adult-onset, dominant myopathy, even
if specific myofibrillar pathology is absent.
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Introduction
Mutations of the human desmin gene on chromosome
2q35 cause familial or sporadic forms of skeletal myopathy,
characterized morphologically by abnormal accumulation of
desmin within muscle fibres (Goebel, 1995). The majority
of cases show autosomal-dominant inheritance, but rare
autosomal-recessive cases as well as an increasing number
of sporadic cases have been reported (Goldfarb et al., 2004).
Several clinical presentations such as rare severe childhood-
onset cardioskeletal myopathy (Goldfarb et al., 1998),
adult-onset skeletal myopathy with cardiac involvement
(Goldfarb et al., 1998; Park et al., 2000a, b; Kaminska et al.,
2004), skeletal myopathy without cardiac involvement
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(Kaminska et al., 2004), severe generalized myopathy (Ariza
et al., 1995), pure dilated cardiomyopathy (Li et al., 1999),
cardiomyopathy with distal weakness (Sugawara et al., 2000;
Goudeau et al., 2001; Schroder et al., 2003) and distal
myopathy with cardiac, respiratory, bulbar and facial involve-
ment (Horowitz and Schmalbruch, 1994; Sjoberg et al., 1999)
were described (OMIM #125660). Most DES mutations were
reported in one family or in a few patients, only. Therefore, it
is difficult to assess whether a distinct clinical phenotype is
closely correlated to a certain mutation or whether certain
mutations cause various clinical presentations.
Recently, we identified a novel DES mutation (R350P) in
a German family with distal myopathy. R350P was shown
to exert a dominant negative effect on the ordered lateral
arrangement of desmin subunits leading to abnormal
protein aggregation. Here we present clinical findings in
15 patients from 5 unrelated families harbouring DES
(R350P) and demonstrate a wide phenotypic spectrum
associated with this mutation including scapuloperoneal
syndrome type Kaeser (OMIM #181400) (Kaeser, 1965).
Material and methods
Patients
A total of 205 unrelated, adult patients with clinical evidence for a
myopathy in scapuloperoneal, distal or limb girdle distribution
were screened for mutations in the desmin gene (see later). DES
(R350P) was detected in five families. All index patients and
affected relatives described in this study were examined by one of
the coauthors. Consanguinity was not reported. Pedigrees were
compatible with autosomal dominant traits. All patients described
are of German descent.
Magnetic resonance imaging
A recently introduced 1.5 tesla scanner (Magnetom Avanto,
Siemens Medical Solutions, Erlangen, Germany) combines 76 coil
elements (‘matrix coils’) and 32 receiver channels. It allows whole
body MRI in all three dimensions with free table movement. The
protocol used for musculoskeletal system on this scanner
incorporates T1-weighted SE (TR 540, TE 13) before and after
intravenous application of Gd-DTPA as contrast-material and
STIR-sequences (TR 2680, TE 101 and TI 150).
Muscle biopsy
An open muscle biopsy was taken from the right vastus lateralis
muscle of patient 9 and from the left gastrocnemius muscle of
patient 13 in family 4 and analysed by standard histological and
immunohistological methods. Protein aggregates were visualized
using antibodies against desmin (Dako M0760, clone D33,
Glostrup, Denmark; dilution 1 : 100), aB-crystallin (Novocastra,
Newcastle Upon Tyne, UK, dilution 1 : 100) and filamin c (clone
RR90; dilution 1 : 3 (van der Ven et al., 2000) and appropriate
secondary antibodies for immunohistochemistry.
Haplotype analysis
Venous blood samples for genomic DNA extraction were collected
with informed consent. Haplotype analysis was performed using
polymorphic microsatellite markers for the chromosomal loci of
LGMD1A–F, MYH2A, CRYAB and DES as recently described (von
der Hagen et al., 2006). For each gene locus, four to six
microsatellite markers flanking the gene on either side were
investigated. The order of markers was based on published human
linkage maps and physical mapping data.
Mutation analysis of the desmin gene (DES)
A PCR fragment encompassing the mutation R350P was amplified
by PCR using primers D6f [50-ATGGCCAGGACCTGACCATT
CTG-30] and D350r [50-TGGCAATCTCCACATCCAGGGCC-30].
The resulting 293 bp fragment was purified using the NucleoSpin
Extract kit (Macherey–Nagel, Du¨ren, Germany), digested with the
restriction endonuclease HpaII (New England Biolabs, Frankfurt,
Germany), and the resulting fragments separated on 2% agarose
gels by electrophoresis. The mutant fragment (R350P) digested
into three fragments of 131, 88 and 74 bp, whereas wild-type DNA
is cleaved into two fragments of 205 and 88 bp length. To confirm
the presence of DES R350P the same PCR product was sequenced
using an Applied Biosystems model 3100 Avant DNA sequencer
and fluorescein-labelled dideoxy terminators (Perkin–Elmer,
Foster City, CA, USA).
Results
Molecular genetics
Linkage analysis was performed in family 1 and 2, and
suggested possible linkage to the DES gene, whereas loci for
LGMD1A–F, MYH2A and CRYAB were excluded. Mutation
screening of DES revealed a heterozygous R350P (1049
G4C) mutation in all affected family members, segregating
with the disease phenotype. The mutation has been
previously described by us in family 4 (Bar et al., 2005).
By screening a cohort of 205 patients, the same mutation
was identified in two additional, unrelated families (families
3 and 5), where it also segregates with the disease.
Haplotype analysis using six microsatellite markers flanking
the desmin gene revealed that the affected family members
in families 1–5 share a common haplotype on one allele
including the gene region which cosegregates with the
R350P mutation (Table 1). In families 3, 4 and 5,
recombination events occurred downstream from the DES
gene region between markers D2S2359 and D2S126 and
between D2S163 and D2S2359, respectively.
Interestingly, the disease allele in all five families shares a
core region of at least 3 Mb with most distal common
microsatellite marker D2S163 (Table 1). This may point
towards a common origin of the mutation (founder allele).
Clinical observations
Family 1çscapuloperoneal phenotype
We examined two affected descendants of the kindred
originally described by Kaeser (1965) with 12 affected
members in five generations following autosomal dominant
inheritance, and a distinct scapuloperoneal distribution of
weakness (Fig. 1). The 60-year-old male index patient
(patient 1, Table 2, Figs 2, 3 and 4) experienced first
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walking difficulties at age 39 years. At age 41 years, paresis
of foot flexors and extensors was noted, and at age 43 years,
shoulder girdle weakness occurred. Ten years after onset of
the disease, the patient became wheelchair-bound; standing
with support was possible up to age 58 years. At
examination at age 60 years, the patient showed pro-
nounced atrophy and weakness of the lower limb and
shoulder girdle muscles as well as a mild involvement of the
facial muscles, dysphagia and gynaecomastia. Whole body
MRI scan showed marked atrophy and fatty degeneration of
proximal and distal muscles, only the biceps brachii muscle
was relatively spared (Fig. 3). CK levels were elevated up to
700 U/l (normal value 580). There was subclinical cardiac
involvement with mild arrhythmia. Genetically, facioscapu-
lohumeral muscular dystrophy (FSHD) was excluded.
EMG showed myogenic findings in various muscles as
well as subtle neurogenic changes in the distal lower
extremities. Morphological and ultrastructural examination
of the biceps brachii muscle revealed unspecific signs of
myopathy. Immunohistochemical staining for desmin and
filamin c was normal except for a few, subsarcolemmal
aggregates in single fibres (Fig. 5).
The 61-year-old sister of the index patient (patient 2,
Table 2) observed mild abdominal weakness between age 40
and 50 years. At age 56 years, mild dysphagia and weakness
of foot extensors occurred. Since age 60 years, she noticed
marked problems in climbing stairs or in getting up from
sitting position due to proximal leg weakness. Two years
later, distal and proximal weakness of arm muscles
developed, and dysphagia worsened. CK levels were only
elevated at 215 U/l (normal value 5167). There is no
cardiac or pulmonary involvement, and the patient is still
able to walk without aids for up to 30 min.
Historical data of the family reveal mean onset of disease
around 40 years of age with earlier onset in male as
compared to female patients. Up to now, 20 persons (11
males, 9 females) from seven generations are reported to be
affected, penetrance seems to be complete.
Family 2çlimb girdle phenotype
In this family, we examined five patients from two
generations with an autosomal dominant myopathy.
The female index patient (patient 3, Table 2, Fig. 4)
showed first symptoms at age 50 years with slowly
progressive proximal leg weakness and cardiac conduction
problems. During the progression of the disease, distal
involvement occurred in leg muscles. However, only mild
proximal paresis was seen in the upper extremity, and no
dysphagia. Since age 70 years, there is severe pulmonary
involvement requiring non-invasive ventilation. CK levels
were normal or mildly elevated. EMG showed a mixed
myopathic–neurogenic pattern, muscle biopsy revealed a
degenerative myopathy with additional neurogenic
changes, fibre-size variations, rimmed vacuoles, whorled
fibres, suggesting myofibrillar myopathy. Additional family
Table 1 Haplotypes of the index patients
Marker Type Location (bp)
Fam 1 Fam 2 Fam 3 Fam 4 Fam 5
Pat 1/VI : 59 Pat 3/V : 4 Pat 8/IV : 2 Pat 9/II : 3 Pat 15/III : 2
D2S164 MS 217568 095 4 3 4 2 4 2 4 1 4 3
D2S2249 MS 218323386 2 4 2 1 2 4 2 3 2 3
D2S2250 MS 219365196 2 1 2 2 2 3 2 1 2 3
c.1049G4C (p.R350P) Mut. 219 994327 C G C G C G C G C G
D2S163 MS 220 400516 3 2 3 1 3 1 3 2 3 3
D2S2359 MS 220553981 2 1 2 3 2 1 3 4 3 3
D2S126 MS 221625158 5 4 5 1 1 2 2 2 3 5
Haplotype analysis of five unrelated R350P patients using six microsatellite markers (MS) flanking the desmin gene and one single
nucleotide polymorphism (SNP).Vertical columns represent individual haplotypes of the analysed patients, whereas each row represents
the genotypes of the MS and the SNP.The markers are listed from centromeric to telomeric; the mutation [1049G4C (R350P)] is shown
in the middle.Genomic locations are from the UCSC reference database via http://www.genome.ucsc.edu/. The haplotype cosegregating
with the R350P mutation has been (representing a putative founder haplotype), while a differing genotype has been retained white.
All patients share a common haplotype stretching from marker D2S164 to D2S163 including the DES gene region.
Fig. 1 Distribution of muscle weakness (from: Kaeser, 1965)
Black: severe weakness/grey: moderate weakness.
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Table 2 Clinical, morphological and genetic findings in R350P desminopathy patients
Patient no./
pedigree
no.
Age
(years)
Sex Age
onset
Initial
symptoms
Distribution
of weakness
MRC grades
(Arms_proximal
Arms_distal
Legs_proximal
Legs_distal)
Additional
signs and
symptoms
CK (U/l) EMG Histology RV Protein
aggregates/
desmin
positive
inclusions
EM
Family 1
1/VI : 59 60 M 39 Climbing stairs
impaired
Scapuloperoneal,
wheel-chair
bound
3^4/5
4^5/5
2^3/5
1^2/5
Dysphagia,
gynaecomas-
tia, cardiac
(mild
arrhythmia),
mild facial
weakness
700 Mixed myo-
pathic/
neurogenic
Mild degenera-
tive
myopathy
 (þ) Z-line disorgani-
zation no
protein
aggregates
2/VI : 58 61 F 40 Abdominal
weakness,
foot drop,
dysphagia
Scapuloperoneal,
still walks
independently
4^5/5
5/5
4/5
4/5
Dysphagia, facial
weakness
215 n.d. n.d. n.d. n.d. n.d.
Family 2
3/V : 4 82 F 50 Climbing stairs
impaired
LGMD, bed-confined 3^4/5
4/5
1^2/5
4/5
Cardiac (conduc-
tion pro-
blems), pul-
monary
(requiring
ventilation)
150 Mainly
myopathic
Degenerative
myopathy
with neuro-
genic-like
changes
 n.d n.d.
4/VI : 15 46 M 30 Myalgia in proxi-
mal leg
muscles
LGMD, walks
independently
5/5
5/5
4/5
5/5
None 400 Normal n.d. n.d. n.d. n.d.
5/VI : 7 y60 M 35 Climbing stairs
impaired
LGMD, wheel-chair
bound
2^3/5
2^3/5
1^2/5
1^2/5
Fatal respira-
tory failure
at age 60
630 Mixed myo-
pathic/
neurogenic
Neurogenic-like
atrophy
þ n.d n.d.
6/VII : 7 41 M 38 Myalgia in proxi-
mal leg
muscles
LGMD, walks
independently
5/5
5/5
4/5
5/5
None 200 Normal n.d. n.d. n.d. n.d.
7/VII : 25 52 M 40 Standing on
heels and
toes
impaired
Distal/LGMD, walks
with support
4/5
5/5
3^4/5
3/5
None 500 Myopathic Degenerative
myopathy
þþ n.d. n.d
Family 3
8/IV : 2 48 M 31 Walking
impaired due
to foot drop
Distal, walks
independently
4^5/5
5/5
4/5
2/5
Mild dysphagia,
gynaecomastia
900 Myopathic Degenerative
myopathy
with neuro-
genic-like
changes
þ Normal Z-line disorgani-
zation
autophagic
vacuoles no
protein
aggregates
(continued )
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Table 2 Continued
Patient no./
pedigree
no.
Age
(years)
Sex Age
onset
Initial
symptoms
Distribution
of weakness
MRC grades
(Arms_proximal
Arms_distal
Legs_proximal
Legs_distal)
Additional
signs and
symptoms
CK (U/l) EMG Histology RV Protein
aggregates/
desmin
positive
inclusions
EM
Family 4
9/II : 3 56 M 48 Dyspnoea on
exertion
LGMD, proximal and
distal weakness in
upper and lower
extremities, walks
independently
4/5
5/5
3/5
4/5
Respiratory
insufficiency
(requiring venti-
lation), cardiac
(arrhythmia),
deafness,
gynaecomastia
2580 Myopathic Degenerative
myopathy
þ þ Z-line streaming
massive
granulofila-
mentous
material
10/I : 2 y44 F n.d. Proximal leg
weakness
LGMD n.d. Sudden cardiac
death at age
44
n.d. n.d. n.d. n.d. n.d. n.d.
11/II : 5 50 F 44 Dyspnoea on
exertion,
proximal leg
weakness
LGMD, proximal and
distal weakness
in lower extre-
mities, walks
independently
5/5
5/5
4/5
4/5
Intermittent pal-
pitations,
exertional
dyspnoea
370 n.d. n.d. n.d. n.d. n.d.
12/II : 1 y46 M 31 Proximal leg
weakness
LGMD, proximal
weakness in
lower
extremities
n.d. Acute cardio-
respiratory
failure at age
46
470 n.d. n.d. n.d. n.d. n.d.
13/III : 1 26 M  No complaints Distal weakness in
lower extremi-
ties, walks
independently
5/5
5/5
5/5
4/5
Deafness 540 Mixed myo-
pathic/
neurogenic
Degenerative
myopathy
with neuro-
genic-like
changes
þ þ n.d
Family 5 n.d. n.d. n.d. n.d.
14/IV : 3 33 F 30 Myalgia, climb-
ing stairs
impaired
LGMD, proximal and
distal weakness
in lower extre-
mities, walks
independently
5/5
5/5
4/5
3/5
Beginning
respiratory
involvement
452 Myopathic n.d. n.d. n.d. n.d.
15/III 0 : 2 64 F 40 Proximal leg
weakness,
foot drop
LGMD, wheelchair-
bound
3/5
4/5
2^3/5
2/5
Respiratory
insufficiency
(requiring
ventilation),
cardiac
(arrhythmia)
108 Myopathic Degenerative
myopathy
þ n.d. n.d.
n.d. ¼ not done; þ ¼ some; þþ ¼ many;  ¼ none; CK ¼ creatine kinase; LGMD ¼ limb girdle muscular dystrophy; EMG ¼ electromyography; EM ¼ electron microscopy;
RV ¼ rimmed vacuoles; y ¼ deceased.
Scapuloperonealsyndrom
e
type
K
aeser
and
desm
in
m
utation
R
350P
Brain
(2007),130,1485
^1496
1489
members (patients 4–7, Table 2) were examined and found
to be similarly affected with a limb girdle distribution of
weakness. Similar to family 1, male patients experienced an
earlier onset and a more severe course of the disease.
Historical data on the family revealed, that 18 patients
(13 males, 7 females) in seven generations were known to
be affected. Assignment (affected/unaffected) for genera-
tions II, III and IV (date of birth around 1780–1900) may
be imperfect, given that a mild clinical presentation at a
higher age may have been missed. Overall, patients show a
limb girdle phenotype, frequently with pronounced cardiac
involvement, and four affected males died from sudden
cardiac events. Furthermore, two affected family members
(one male, one female) show marked pulmonary involve-
ment requiring non-invasive ventilation.
Family 3çdistal myopathy phenotype
First symptoms occurred at age 31 years in the now
50-year-old male index patient (patient 8, Table 2, Fig. 4)
as distal leg weakness predominantly in foot extensors.
Ten years later, abdominal weakness, mildly progressive
proximal leg weakness and gynaecomastia were noted. Since
age 46 years, dysphagia and proximal arm weakness
additionally occurred, but up to now we observed no
signs of cardiac or pulmonary impairment. CK levels were
elevated between 300 and 1000 U/l (normal value 5180).
Histologically, a myopathy with rimmed vacuoles was
diagnosed; Z-line disorganization and autophagic vacuoles
were observed by electron microscopy. Whole body MRI
scan showed symmetric atrophy and degeneration of
deltoideus muscles, while biceps brachii, supra- and
infraspinatus muscles are relatively spared (Fig. 3).
Furthermore, there was marked involvement of trunk
muscles, proximal and distal lower-limb muscles with
predominance of fatty degeneration in tibialis anterior
muscles. Six individuals (three males, three females) from
four generations are known to be affected.
Family 4çmixed distal myopathy/limb girdle phenotype
This family harbouring the R350P mutation has been
recently described by us (Bar et al., 2005) and re-examined
for the purpose of this study. The index patient is a
56-year-old male presenting with a history of increasing
dyspnoea on exertion starting in his mid-forties (patient 9,
Table 2, Fig. 4). Neuromuscular symptoms with difficulty
in lifting his arms over shoulder level were first noted at age
48 years. Neurological examination showed mild bilateral
weakness of proximal arm and shoulder girdle muscles and
moderate weakness of both pelvic and proximal leg
muscles. In addition, he exhibited mild weakness of distal
leg muscles and showed mild gynaecomastia. Respiratory
and cardiac work-up showed a restrictive ventilation
disorder and a cardiomyopathy with conduction disorder.
EMG showed a myopathic pattern, nerve conduction
velocity was normal. Biopsy of his vastus lateralis muscle
revealed myopathic findings including increased fibre-size
variation, internalized myonuclei, rare angulated atrophic
fibres, multiple fibres with cytoplasmic and subsarcolemmal
basophilic inclusions and conspicuous cytoplasmic protein
aggregates in a large number of myofibres. These aggregates
were immunoreactive for desmin and aB-crystallin (Fig. 5).
Several other family members were similarly affected
(patients 10–13, Table 2). His mother suffered from slowly
progressive leg weakness and died at age 44 years because of
acute cardiac failure (patient 10, Table 2). His 50-year-old
sister reported progressive muscle weakness and dyspnoea
on exertion, starting at age 44 years. Her neurological
examination demonstrated moderate weakness of distal and
proximal leg muscles (patient 11, Table 2). His brother
suffered from proximal leg weakness starting at age 31 years
and died at age 46 years because of progressive cardio-
respiratory insufficiency (patient 12, Table 2). One out of
four offspring of patient 12 showed mild weakness of foot
extensor muscles (patient 13 in Table 2). Muscle biopsy
taken from the gastrocnemius muscle revealed a myopathic
Fig. 2 Clinical picture of patient 1. Note the scapuloperoneal
pattern of weakness along with gynaecomastia.
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Fig. 3 Whole body MRI scans (T1-weighted images) and transverse sections of upper and lower-limb muscles. Patient 8: (left) symmetric
atrophy and degeneration of deltoideus muscles, while biceps brachii, supra- and infraspinatus muscles are relatively spared. Note the
marked involvement of trunk muscles, proximal and distal lower-limb muscles with predominance of fatty degeneration in tibialis anterior
muscles. Patient14: (middle) marked atrophy and fatty degeneration of proximal and distal legmuscles, predominantly in the dorsal
leg compartment, while in the upper extremities only deltoideus muscles are mildly affected. Patient 1: (right) marked atrophy and fatty
degeneration of proximal and distal muscles, only the biceps brachii muscle is relatively spared.
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Fig. 4 Pedigrees of families. Families 1^5, index patients are described inTable 1.
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Fig. 4 Continued.
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pattern with rounding of muscle fibres, increased fibre-size
variability with diameters ranging from 16 to 153 mm
(normal 40–80 mm), some necrotic and regenerating fibres,
internalization of nuclei in 40% of the fibres and many
fibres with basophilic inclusions which showed intense
labelling with antibodies against desmin and aB-crystallin
(Fig. 5).
Family 5çlimb girdle phenotype
The 33-year-old female index patient (patient 14, Table 2,
Fig. 4) noticed myalgia after exercise since age 16 years. At
age 30 years, she noted first problems in climbing stairs.
Around the same time she noticed an inability to walk on
heels. Neurological examination at age 33 years revealed
paresis of proximal leg muscles (MRC 4/5) and foot
extensors (3/5), but full strength of foot flexors, arm and
hand muscles. Lung function tests showed beginning
respiratory involvement, cardiac function was normal.
Whole body MRI scan showed marked atrophy and
fatty degeneration of proximal and distal leg muscles,
predominantly in the dorsal leg compartment, while in the
upper extremities only deltoid muscles are mildly
affected (Fig. 3).
The 64-year-old mother (patient 15, Table 2) of the
index patient noted first symptoms at age 40 years in form
of proximal leg weakness, foot drop and cardiac arrhyth-
mia. At age 45 years additional weakness in shoulder girdle
and arm muscles occurred, at age 55 years, finger flexors
were also affected. From age 58 years, she used a walking
frame, and is now wheelchair-bound. Meanwhile, her lung
function deteriorated requiring non-invasive ventilation.
A muscle biopsy was obtained 25 years ago and showed a
vacuolar myopathy, suggestive of inclusion body myopathy.
Ultrastructural and immunohistochemical analysis was not
carried out.
Her father and a male paternal cousin both died from
sudden cardiac death at age 53 and 56 years, respectively,
the cousin was further reported to have suffered from
muscle weakness.
Discussion
We report clinical, electrophysiological, histopathological
and molecular data of 15 patients from five independent
families affected with a dominant myopathy due to DES
(R350P), presenting with a highly variable clinical and
morphological phenotype. Up to now, more than 30
mutations in DES have been reported and some tentative
genotype–phenotype correlations have been proposed based
on the mutation site, inheritance pattern and clinical
manifestations (Goldfarb et al., 2004; Paulin and Li, 2004).
However, no distinct clinical phenotype was found to be
closely associated with a certain mutation, since most
mutations were limited to a single or few families. Clinical
manifestations in the autosomal dominant syndrome
included distal or proximal progressive skeletal myopathy,
cardiomyopathy and respiratory dysfunction alone or their
combination (Goldfarb et al., 2004). For the first time we
describe a larger cohort of patients harbouring the same
DES mutation (R350P). Large variability was recognized,
(Table 3) even within the same family, ranging from
scapuloperoneal (n¼ 2, 12%), limb girdle (n¼ 10, 60%)
and distal phenotypes (n¼ 3, 18%) with variable cardiac
(n¼ 7, 41%) or respiratory involvement (n¼ 7, 41%). In
advanced stages of the disease, all muscles are affected,
but the biceps bracchii is relatively spared in patients
Fig. 5 Histological analysis and immunohistochemistry of muscle specimen of patient 1 (A^D) and patient 13 (E and F). Serial sections:
(A) H&E: in addition to normal myofibres, rarely angulated atrophic fibres are found (asterisks). (B) NADH: dark angulated myofibres
are suspicious for protein aggregates (asterisks). (C) Desmin staining reveals only limited positive staining of subsarcolemmal aggregates.
(D) Filamin-c staining shows more pronounced marking of subsarcolemmal aggregates. (E) H&E: myopathic findings are shown,
including increase in fibre-size variation, internalized myonuclei and rarely angulated atrophic fibres. (F) NADH: dark myofibres are
suspicious for protein aggregates. Serial sections: (G) anti-desmin staining and (H) anti-alpha-B-crystallin staining show positive marking of
subsarcolemmal and intracytoplasmic aggregates (asterisks indicate corresponding fibres). Bars in (A) and (E): 30mm.
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with scapuloperoneal distribution. In addition, facial
weakness, dysphagia and gynaecomastia were frequently
observed.
Desminopathy (R350P) is inherited with an autosomal
dominant pattern and shows full penetrance. Mean onset of
disease of male patients was at age 37 years. In female
patients, disease onset occurred later (mean at age 46
years), and progression seemed less severe. While males do
not have a higher overall incidence of cardiac or pulmonary
involvement compared to females, risk for sudden death
or fatal respiratory failure seems to be higher in males: 2
males versus 1 female in the patients investigated for this
study, and 12 males versus 2 females from families’
historical data. Therefore, gender-related factors or modifier
genes may be involved in determining disease onset
and severity. Recently, similar gender-related phenotypic
differences have been described in a Spanish desminopathy
family due to a novel L370P mutation (Arias et al., 2006).
Furthermore, it would be important to identify genetic
associations responsible for heart and respiratory problems,
like mutations in other ‘neuromuscular’ genes modifying
the clinical manifestation or synergistically contribute to
disease severity of desminopathy, which was recently shown
for dominant Emery–Dreifuss muscular dystrophy by
mutations in both emerin and desmin proteins (Muntoni
et al., 2006).
DES R350P is relatively frequent in German patients with
dominant, adult-onset myopathies. Other populations were
not represented in our cohort of patients. Since the
mutation was detected in five unrelated families, we
wondered whether position 350 is a mutation hotspot. In
this case, the mutation would have arisen independently on
divergent alleles. In contrast, we found the allele harbouring
R350P in all five families associated with the same array of
extragenic, polymorphic markers which spans at least 3 Mb.
This argues strongly for a founder allele, i.e. the mutation
arose only once several centuries ago to allow for the
observed recombination events at adjacent flanking
markers.
Usually, desminopathies are diagnosed through muscle
histology. Pathological features in desminopathies consist of
a myopathic pattern with variability of fibre-size, the
presence of angulated atrophic fibres, internalized nuclei,
rimmed and autophagic vacuoles, rarely cytoplasmic
eosinophilic inclusions and accumulation of desmin in
immunohistochemistry. Furthermore, in autophagic
vacuoles myelin-like lamellae, aggregates, and IBM-like
paired helical tubulofilaments were described (Vrabie
et al., 2005). Selcen et al. (2004) reported in a cohort of
patients with myofibrillar myopathy an abnormal fibre-size
variation, with some fibre diameters as small as 5 mm or as
large as 150 mm and type-grouping in 70% of the muscle
specimens. In most cases, however, atrophic fibres
accounted for only a small proportion of the total.
Furthermore, neurogenic-like changes are described in
other myofibrillar myopathies such as myotilinopathy
(Selcen and Engel, 2004) and ZASPopathy (Selcen and
Engel, 2005).
In 1965, Kaeser reported a kindred with atrophies and
weakness in a scapuloperoneal distribution following an
autosomal dominant trait. Histopathological examination at
autopsy in one patient, the father of our index patient
(patient 1, family 1), revealed fibre-size variation ranging
from 12 to 54 mm, increase in muscle nuclei and small
muscle fibres with varying shapes (some very small and
round, others polyhedral) found in biceps, quadriceps,
interosseus dorsalis and thenar muscles (Probst et al.,
1977). However, clear myofibrillar changes are not
reported. Ultrastructural findings were described as
‘a juxtanuclear inclusion which consisted of a crystal-like
lattice of dense particles’, that may resemble protein
aggregates. Retrospectively, there is considerable overlap
with the myopathological changes described in myofibrillar
myopathies. Kaeser suggested a neurogenic origin, but
demonstrated significant differences from the cases reported
by Davidenkow (1939). Neuropathic scapuloperoneal syn-
drome (Davidenkow’s syndrome) was recently found
associated to chromosome 17p11.2 deletions (Verma,
2005). Interestingly, the current histopathological examina-
tion of the biceps brachii muscle of patient 1 showed very
limited myofibrillar changes or protein aggregation which
were only picked up by desmin and filamin c immunohis-
tochemistry. Therefore, we suggest to proceed with genetic
analysis in adult-onset, dominant myopathies even in the
absence of typical, myofibrillar changes upon histological
examination, once other causes of dominant myopathies
have been excluded.
Our findings allow re-assigning the scapuloperoneal
syndrome in the kindred originally described by Kaeser to
the group of dominant myopathies, due to the R350P
desmin mutation. Future studies will have to elucidate how
other factors and modifier genes may influence the severity,
penetrance and expression of the disease. Identification of
these genes and pathways may lead to novel therapeutic
strategies.
Table 3 Clinical phenotype of DES R350P patients
All patients
(n¼15)
Males
(n¼ 9)
Females
(n¼ 6)
Mean age of onset (years) 4010 375 4613
Onset proximal 11 6 5
Onset distal 4 3 1
Distal4proximal weakness 4 2 2
Proximal4distal weakness 8 4 4
Scapuloperoneal weakness 2 1 1
Swallowing problems 4 3 1
Facial weakness 2 1 1
Gynaecomastia 3
Respiratory involvement 7 3 4
Cardiac involvement 7 3 4
Death560 years 3 2 1
CK level (normal5160) 557145 739 213 256131
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